Factors affecting burden of psychopharmacological medication in patients with autism spectrum disorder: the importance of early diagnosis -

Q Medicine

Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology Pub Date : 2016-11-08 DOI:10.5455/BCP.20151230063042

Şahin Bodur, C. Taşkıran, Yetiş Işıldar, Burcu Ersoz Alan, M. Çetinkaya, H. Kara, M. Şahin, S. Turgut

{"title":"Factors affecting burden of psychopharmacological medication in patients with autism spectrum disorder: the importance of early diagnosis -","authors":"Şahin Bodur, C. Taşkıran, Yetiş Işıldar, Burcu Ersoz Alan, M. Çetinkaya, H. Kara, M. Şahin, S. Turgut","doi":"10.5455/BCP.20151230063042","DOIUrl":null,"url":null,"abstract":"ABSTRACTObjective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis.Methods: Five hundred and twenty three children with ASD who applied to Dr. Sami Ulus Maternity and Children Research and Training Hospital between 2010–2015 were reviewed retrospectively. Data has been obtained from computerized hospital information system. Individuals with the diagnosis of Autism (F84.0), Atypical Autism (F84.1) and Pervasive Developmental Disorder Not Other Specified (F84.9) were screened.Results: Psychotropic medication was recommended to 28.5% of the 523 children and adolescents diagnosed with ASD. Antipsychotics were the most common drugs of choice among psychotropic medications. The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p<0.01). The rate of psychot...","PeriodicalId":17852,"journal":{"name":"Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/BCP.20151230063042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 2

Abstract

ABSTRACTObjective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis.Methods: Five hundred and twenty three children with ASD who applied to Dr. Sami Ulus Maternity and Children Research and Training Hospital between 2010–2015 were reviewed retrospectively. Data has been obtained from computerized hospital information system. Individuals with the diagnosis of Autism (F84.0), Atypical Autism (F84.1) and Pervasive Developmental Disorder Not Other Specified (F84.9) were screened.Results: Psychotropic medication was recommended to 28.5% of the 523 children and adolescents diagnosed with ASD. Antipsychotics were the most common drugs of choice among psychotropic medications. The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p<0.01). The rate of psychot...

查看原文本刊更多论文

影响自闭症谱系障碍患者精神药物负担的因素:早期诊断的重要性

摘要目的:了解自闭症谱系障碍(ASD)患儿的精神药理学用药频率，确定其诊断年龄范围。方法:对2010-2015年在Sami Ulus妇幼研究培训医院就诊的523例ASD患儿进行回顾性分析。数据来源于计算机化的医院信息系统。对诊断为自闭症(F84.0)、非典型自闭症(F84.1)和非其他特定的广泛性发育障碍(F84.9)的个体进行筛查。结果:523例诊断为ASD的儿童和青少年中有28.5%推荐精神药物治疗。抗精神病药物是精神药物中最常见的选择。服用精神药物的患者诊断时平均年龄显著高于未服用精神药物的患者(t=-3.064;p < 0.01)。精神病发病率…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology 医学-精神病学

CiteScore

0.34

自引率

0.00%

发文量

审稿时长

6-12 weeks